Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EmbryoScope+

K-Number: K173264 · 2018-05-11

ApplicantVitrolife A/S
Decision Date2018-05-11
Product CodeMQG
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

EmbryoScope+ is a medical device manufactured by Vitrolife A/S. It received FDA 510(k) clearance on 2018-05-11 under approval number K173264. The device is classified under product code MQG. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EmbryoScope+?

EmbryoScope+ is a medical device that received FDA 510(k) clearance on 2018-05-11. It is manufactured by Vitrolife A/S. The 510(k) number is K173264.

When was EmbryoScope+ approved by the FDA?

EmbryoScope+ received FDA 510(k) clearance on 2018-05-11, under approval number K173264.

What company makes EmbryoScope+?

EmbryoScope+ is manufactured by Vitrolife A/S.

What is the FDA product code for EmbryoScope+?

The FDA product code for EmbryoScope+ is MQG.

Other Devices by Vitrolife A/S

Related Devices (Code: MQG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.